QUEST DIAGNOSTICS ($DGX) posted quarterly earnings results on Tuesday, April 22nd. The company reported earnings of $2.21 per share, beating estimates of $2.17 by $0.04. The company also reported revenue of $2,652,000,000, missing estimates of $2,656,347,540 by $-4,347,540.
You can see Quiver Quantitative's $DGX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
QUEST DIAGNOSTICS Insider Trading Activity
QUEST DIAGNOSTICS insiders have traded $DGX stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- CATHERINE T. DOHERTY (EVP, Regional Businesses) has made 0 purchases and 7 sales selling 41,447 shares for an estimated $6,843,173.
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 6 sales selling 41,513 shares for an estimated $6,819,095.
- J. E. DAVIS (CEO and President) has made 0 purchases and 15 sales selling 39,191 shares for an estimated $6,602,074.
- MICHAEL J DEPPE (SVP, Corp. Controller & CAO) has made 0 purchases and 6 sales selling 18,755 shares for an estimated $2,889,122.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 2 sales selling 4,330 shares for an estimated $712,875.
- VICKY B GREGG sold 1,250 shares for an estimated $205,710
- MARK E DELANEY (SVP & Chief Commercial Officer) sold 403 shares for an estimated $66,214
- PATRICK PLEWMAN (SVP for Diagnostic Services) sold 320 shares for an estimated $54,307
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
QUEST DIAGNOSTICS Hedge Fund Activity
We have seen 379 institutional investors add shares of QUEST DIAGNOSTICS stock to their portfolio, and 360 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,637,525 shares (+42.5%) to their portfolio in Q4 2024, for an estimated $247,037,021
- JPMORGAN CHASE & CO added 916,898 shares (+60.4%) to their portfolio in Q4 2024, for an estimated $138,323,232
- AMERICAN CENTURY COMPANIES INC removed 764,962 shares (-33.4%) from their portfolio in Q4 2024, for an estimated $115,402,167
- CITADEL ADVISORS LLC removed 748,133 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $112,863,344
- UBS GROUP AG added 588,478 shares (+156.3%) to their portfolio in Q4 2024, for an estimated $88,777,791
- WELLINGTON MANAGEMENT GROUP LLP removed 549,280 shares (-23.5%) from their portfolio in Q4 2024, for an estimated $82,864,380
- ALLIANCEBERNSTEIN L.P. added 497,995 shares (+83.7%) to their portfolio in Q4 2024, for an estimated $75,127,525
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
QUEST DIAGNOSTICS Government Contracts
We have seen $126,912,117 of award payments to $DGX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TASK ORDER FOR REF LAB BRIDGE WHILE SOLIITATION IS CURRENTLY ACTIVE TO AVOID SERVICE DISRUPTION.: $7,903,000
- PRIMARY REFERENCE LAB SERVICES, PSC BLOOD DRAW AND COURIER SERVICES: $3,857,142
- REFERENCE LAB TESTS: $3,748,684
- REFERENCE LAB TESTING - 6-MO EXT: $3,059,689
- REFERENCE LAB TESTS FOR ORLANDO VAHCS 675C50020: $2,700,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
QUEST DIAGNOSTICS Congressional Stock Trading
Members of Congress have traded $DGX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DGX stock by members of Congress over the last 6 months:
- REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
QUEST DIAGNOSTICS Price Targets
Multiple analysts have issued price targets for $DGX recently. We have seen 4 analysts offer price targets for $DGX in the last 6 months, with a median target of $185.5.
Here are some recent targets:
- Jamie Clark from Redburn Partners set a target price of $195.0 on 04/02/2025
- David Westenberg from Piper Sandler set a target price of $180.0 on 02/03/2025
- David MacDonald from Truist Financial set a target price of $182.0 on 01/31/2025
- Eric Coldwell from Robert W. Baird set a target price of $189.0 on 01/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
